Shiuey Y, Eisenberg M J
Department of Medicine and Cardiology Division of the University of California, San Francisco, USA.
Clin Cardiol. 1996 Jan;19(1):5-8. doi: 10.1002/clc.4960190104.
Eye disease and cardiovascular disease frequently coexist. As a result, cardiologists and ophthalmologists often treat the same patients. Among ophthalmologists it is well known that topical ophthalmic medications are capable of producing serious cardiovascular effects, including congestive heart failure, arrhythmias, and death. However, cardiologists may not be aware of these potential complications. This article reviews the cardiovascular effects of commonly prescribed topical ocular medications and describes important contraindications to their use in patients with cardiovascular disease. Cardiologists, by making themselves and their patients more aware of the cardiovascular effects of topical ocular medications, may be able to avoid the adverse and potentially fatal complications of these agents.
眼部疾病和心血管疾病常常并存。因此,心脏病专家和眼科医生经常会治疗同一批患者。在眼科医生中,众所周知局部眼科药物能够产生严重的心血管效应,包括充血性心力衰竭、心律失常和死亡。然而,心脏病专家可能并不知晓这些潜在的并发症。本文回顾了常用局部眼部药物的心血管效应,并描述了其在心血管疾病患者中使用的重要禁忌证。心脏病专家通过让自己和患者更多地了解局部眼部药物的心血管效应,或许能够避免这些药物的不良及潜在致命并发症。